Is It Time To Review Stock News? DURECT Corporation (NASDAQ:DRRX)
DURECT Corporation (NASDAQ:DRRX) stock identified change of 295.65% away from 52-week low price and recently located move of -26.02% off 52-week high price. It has market worth of $349.39M. DRRX stock has been recorded 0.19% away from 50 day moving average and 81.36% away from 200 day moving average. Moving closer, we can see that shares have been trading -2.62% off 20-day moving average.
On Oct. 30, 2019, DURECT Corporation (NASDAQ:DRRX) reported that it will report third quarter and nine months ended September 30, 2019 financial results and host a conference call after the market close on Monday, November 4, 2019.
About DURECT Corporation
DURECT is a biopharmaceutical company actively developing therapeutics based on its Epigenetic Regulator Program and proprietary drug delivery platforms. DUR 928, a new chemical entity in Phase 2 development, is the lead candidate in DURECT’s Epigenetic Regulator Program. An endogenous, orally bioavailable small molecule, DUR-928 has been shown in preclinical studies to play an important regulatory role in lipid homeostasis, inflammation, and cell survival. Human applications may include acute organ injury such as alcoholic hepatitis (AH) and acute kidney injury (AKI), chronic hepatic diseases such as nonalcoholic steatohepatitis (NASH), and inflammatory skin conditions such as psoriasis and atopic dermatitis. DURECT’s advanced oral and injectable delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs. Key product candidates in this category include POSIMIR® (bupivacaine extended-release solution), an investigational locally-acting, non-opioid analgesic intended to provide up to 3 days of continuous pain relief after surgery, a long-acting injectable SABER-based HIV investigational product being developed with Gilead.
The Healthcare sector company, DURECT Corporation noticed change of -4.21% to $1.82 along volume of 508169 shares in recent session compared to an average volume of 914.38K. The stock observed return of -6.67% in 5 days trading activity. The stock was at 7.69%over one month performance. DRRX’s shares are at 66.97% for the quarter and driving a 80.20% return over the course of the past year and is now at 276.73% since this point in 2018.
The average volatility for the week at 5.37% and for month was at 6.66%. There are 191.97M shares outstanding and 185.48M shares are floated in market. Right now the stock beta is 1.76.
Greg Downing is passionate about business news with over 5 years in the industry starting as a writer working his way up into senior positions. He is the driving force behind analystsbuzz.com with a vision to broaden the company’s readership throughout 2016.Greg Downingis a Master in Business Administration by education. After completing her post-graduation, Gregjumped the journalism bandwagon as a freelance journalist.
Address: 15666 Southeast 42nd Lane, Bellevue, WA 98006 USA